Glioblastoma continues to be one of the most challenging cancers to treat as it resists even the latest innovations in immunotherapy. Now, a new stud ...
Rising leukemia rates in Florida linked to aging population, new treatment guidelines for follicular lymphoma, a new study that may help unlock immunotherapy for glioblastoma, and more are in this ...
Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy ...
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...
Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...
Glioblastoma has remained one of the toughest cancers to treat, but new research suggests that suppressing a protein (ZNF638) ...
ELF4, a transcription factor of the ETS family, shows potential in tumor suppression and oncogenesis (1 Trusted Source Transcription factor ELF4 in physiology and diseases: Molecular roles ...